Point-Counterpoint: What’s in a Name? Cancer by Any Other Name Is Still Cancer: The Flawed Argument for Renaming Grade Group 1/Gleason Score 3+3=6 Disease
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2023.
All research outputs
#5,942,593
of 27,791,073 outputs
Outputs from The Journal of Urology
#4,121
of 19,786 outputs
Outputs of similar age
#105,425
of 422,031 outputs
Outputs of similar age from The Journal of Urology
#98
of 227 outputs
Altmetric has tracked 27,791,073 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,786 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 422,031 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 227 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
